SCHEMBL7052349

SCHEMBL7052349

C#CN(C(=O)c1ccccc1)c1ccccc1S(=O)(=O)NC(=O)C(C)(C)C.c1cc2ccc1-2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
LMNA P02545 2/20 0.34
GAA P10253 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
AGTR1 P30556 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
POLB P06746 1/20 0.34
TBXA2R P21731 2/20 0.33
PTGER1 P34995 2/20 0.33
PTGER4 P35408 2/20 0.33
PTGFR P43088 2/20 0.33
PTGER3 P43115 2/20 0.33
PTGIR P43119 2/20 0.33
PTGDR Q13258 2/20 0.33
HSD11B1 P28845 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049851 0.88 AKR1C2 (0.38) MAPTALDH1A1HPGDLMNAGAA
SCHEMBL7052307 0.83 ALDH1A1 (0.33) MAPTALDH1A1HPGDLMNAKDM4E
SCHEMBL7076349 0.81 BCL2L1 (0.43) LMNAHSD11B1PTGES
SCHEMBL7050679 0.81 ALDH1A1 (0.32) MAPTALDH1A1HPGDLMNAAGTR1
SCHEMBL7048489 0.81 POLB (0.43) MAPTALDH1A1HPGDGAAAGTR1
SCHEMBL7051028 0.80 POLB (0.42) HPGDGAAMEN1AGTR1KMT2A
SCHEMBL7049824 0.80 HPGD (0.36) MAPTALDH1A1HPGDGAAAGTR1
SCHEMBL7076569 0.74 SMPD1 (0.53)
SCHEMBL19627399 0.68 POLB (0.54) ALDH1A1GAAMEN1KMT2APOLB
SCHEMBL13764330 0.66 PPARA (0.57) ALDH1A1HPGDLMNAKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030191323-A1 Hypoglycemic agent AJINOMOTO CO., INC. (JP) 2003-10-09 US disclosed
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed
EP-1300142-A1 HYPOGLYCEMICS Ajinomoto Co., Inc. (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN MAPT 3922/4885ALDH1A1 385/4885HPGD 3434/4885
US-20030191323-A1 Hypoglycemic agent GPR119, IAPP, SLC5A2 MAPT 4390/4885ALDH1A1 410/4885HPGD 1451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.